Assertio Holdings (ASRT) said, on May 1, 2026, Assertio and Garda Therapeutics entered into an Amended and Restated Agreement and Plan of Merger, pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.
Following the successful completion of the tender offer, Garda will acquire any remaining shares through a second-step merger at the same price. Upon completion, Assertio's common stock will no longer be listed on Nasdaq.
In pre-market trading on NasdaqCM, Assertio shares are up 17.27 percent to $21.66.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.